[go: up one dir, main page]

FR2893845B1 - Composition sous forme de spray comprenant un corticoide et une phase huileuse - Google Patents

Composition sous forme de spray comprenant un corticoide et une phase huileuse

Info

Publication number
FR2893845B1
FR2893845B1 FR0512176A FR0512176A FR2893845B1 FR 2893845 B1 FR2893845 B1 FR 2893845B1 FR 0512176 A FR0512176 A FR 0512176A FR 0512176 A FR0512176 A FR 0512176A FR 2893845 B1 FR2893845 B1 FR 2893845B1
Authority
FR
France
Prior art keywords
corticide
oily phase
spray composition
spray
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0512176A
Other languages
English (en)
Other versions
FR2893845A1 (fr
Inventor
Nathalie Willcox
Sandrine Orsoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Priority to FR0512176A priority Critical patent/FR2893845B1/fr
Priority to CA2631123A priority patent/CA2631123C/fr
Priority to PCT/FR2006/051259 priority patent/WO2007063254A1/fr
Priority to EP06842070A priority patent/EP1959927A1/fr
Publication of FR2893845A1 publication Critical patent/FR2893845A1/fr
Priority to US12/128,975 priority patent/US20080300229A1/en
Application granted granted Critical
Publication of FR2893845B1 publication Critical patent/FR2893845B1/fr
Priority to US13/038,483 priority patent/US20110152228A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0512176A 2005-11-30 2005-11-30 Composition sous forme de spray comprenant un corticoide et une phase huileuse Expired - Fee Related FR2893845B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0512176A FR2893845B1 (fr) 2005-11-30 2005-11-30 Composition sous forme de spray comprenant un corticoide et une phase huileuse
CA2631123A CA2631123C (fr) 2005-11-30 2006-11-30 Composition sous forme de spray comprenant un corticoide et une phase huileuse
PCT/FR2006/051259 WO2007063254A1 (fr) 2005-11-30 2006-11-30 Composition sous forme de spray comprenant un corticoide et une phase huileuse
EP06842070A EP1959927A1 (fr) 2005-11-30 2006-11-30 Composition sous forme de spray comprenant un corticoide et une phase huileuse
US12/128,975 US20080300229A1 (en) 2005-11-30 2008-05-29 Sprayable pharmaceutical compositions comprising a corticoid and an oily phase
US13/038,483 US20110152228A1 (en) 2005-11-30 2011-03-02 Sprayable pharmaceutical compositions comprising a corticoid and an oily phase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0512176A FR2893845B1 (fr) 2005-11-30 2005-11-30 Composition sous forme de spray comprenant un corticoide et une phase huileuse

Publications (2)

Publication Number Publication Date
FR2893845A1 FR2893845A1 (fr) 2007-06-01
FR2893845B1 true FR2893845B1 (fr) 2010-10-29

Family

ID=36716957

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0512176A Expired - Fee Related FR2893845B1 (fr) 2005-11-30 2005-11-30 Composition sous forme de spray comprenant un corticoide et une phase huileuse

Country Status (5)

Country Link
US (2) US20080300229A1 (fr)
EP (1) EP1959927A1 (fr)
CA (1) CA2631123C (fr)
FR (1) FR2893845B1 (fr)
WO (1) WO2007063254A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
EP2397034A1 (fr) 2005-07-14 2011-12-21 Lithera, Inc. Formulation lipolytique améliorée à libération prolongée pour le traitement régional des tissus adipeux
GB2443287B (en) * 2006-10-17 2009-05-27 Lipothera Inc Methods, compositions and formulations for the treatment of thyroid eye disease
US9132084B2 (en) * 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
EP3141246A1 (fr) 2009-08-31 2017-03-15 Dr. Reddy's Laboratories Ltd. Formules topiques comprenant un stéroïde
EP2523667A4 (fr) * 2010-01-15 2014-04-02 Lithera Inc Préparations pour gâteaux lyophilisés
PL2456445T3 (pl) * 2010-06-25 2014-10-31 G Pohl Boskamp Gmbh & Co Kg Środek do leczenia chorób skóry
WO2012071480A2 (fr) * 2010-11-24 2012-05-31 Lithera, Inc. Formulations monothérapeutiques de glucocorticostéroïdes lipophiles et procédés pour le traitement cosmétique de l'adiposité et du bombement de la silhouette
KR20140025312A (ko) 2010-11-24 2014-03-04 리쎄라 인코오포레이티드 지방증 및 윤곽 팽창의 미용적 치료를 위한 선택적인, 친유성, 및 지속성 베타 작용제 단일치료 제형 및 방법
AU2012251135A1 (en) * 2011-05-02 2013-11-07 Lipidor Ab Treatment of psoriasis
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
CA3037582A1 (fr) 2016-09-21 2018-03-29 Avexxin As Composition pharmaceutique
GB201616088D0 (en) * 2016-09-21 2016-11-02 Avexxin As Pharmaceutical composition
US20190008969A1 (en) * 2017-07-06 2019-01-10 Tioga Research, Inc. Compositions for drug delivery
WO2019224035A1 (fr) 2018-05-24 2019-11-28 Almirall, S.A. Compositions pharmaceutiques topiques comprenant un corticostéroïde

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343798A (en) * 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
US5972920A (en) * 1998-02-12 1999-10-26 Dermalogix Partners, Inc. Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6579512B2 (en) * 2001-06-15 2003-06-17 Crutchfield, Iii Charles E. Topical steroid spray
CA2502986C (fr) * 2002-10-25 2011-08-23 Foamix Ltd. Mousse cosmetique et pharmaceutique
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
MXPA06005587A (es) * 2003-11-21 2006-08-11 Galderma Res & Dev Composicion rociable para administracion de derivados de vitamina d.
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
KR101243526B1 (ko) * 2004-08-31 2013-03-20 스티펠 리서치 오스트레일리아 피티와이 리미티드 마이크로에멀젼 및 서브마이크론 에멀젼 방법 및 조성물

Also Published As

Publication number Publication date
FR2893845A1 (fr) 2007-06-01
WO2007063254A1 (fr) 2007-06-07
EP1959927A1 (fr) 2008-08-27
CA2631123C (fr) 2014-01-21
US20110152228A1 (en) 2011-06-23
US20080300229A1 (en) 2008-12-04
CA2631123A1 (fr) 2007-06-07

Similar Documents

Publication Publication Date Title
FR2893845B1 (fr) Composition sous forme de spray comprenant un corticoide et une phase huileuse
FR16C1000I2 (fr) Compositions comprenant des polypeptides
EP1736516A4 (fr) Composition de revêtement antisalisure
DE602005026291D1 (de) Flüssige pestizidzusammensetzungen
DE602004010873D1 (de) Phasenaustauschtintenzusammensetzungen
IL188915A0 (en) Liquid formulations
EP1867706A4 (fr) Composition de graisse
IL186673A0 (en) Stable emulsion composition
EP1704848A4 (fr) Composition demaquillante huileuse
ATE453384T1 (de) Neue dosierformulierung
DK1809328T3 (da) Mannooligosaccharid-sammensætning til kropsfedt-reduktion
TWI370115B (en) New formulation
DE602005027222D1 (de) Schaumbare zusammensetzung
DK1828148T3 (da) Triazolsubstituerede aminobenzophenonforbindelser
DK1941798T3 (da) Nematicide præparater
FR2865401B1 (fr) Composition de nettoyage de la peau
DE602005007714D1 (de) Neue quaternisierte chinuclidinester
EP1778734A4 (fr) Composition de pulverisation comportant un agent de regulation du depot
FR2871700B1 (fr) Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
ZA200703708B (en) Liquid detergent composition
FR2913887B1 (fr) Composition sous forme de gel comprenant une substance odorante
FR2893847B1 (fr) Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
ES1058248Y (es) Pieza de recubrimiento para suelos y paredes.
EP1813666A4 (fr) Composition detergente liquide
PL1602289T3 (pl) Pastowata kompozycja na sosy i podobne

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160729